세계의 CBD 오일 및 CBD 컨슈머 헬스 시장 : 시장 규모, 점유율, 동향 분석(제품별, 지역별), 부문별 예측(2025-2030년)

CBD Oil & CBD Consumer Health Market Size, Share & Trends Analysis Report By Product (CBD Oil, CBD Consumer Health), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,374,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,782,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,597,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

CBD 오일 및 CBD 컨슈머 헬스 시장의 성장과 동향 :

Grand View Research, Inc.의 새로운 보고서에 따르면 세계 CBD 오일 및 CBD 컨슈머 헬스 시장 규모는 2025년부터 2030년까지 20.9%의 연평균 복합 성장률(CAGR)을 기록하며, 2030년까지 2,159억 달러에 달할 것으로 예측됩니다.

칸나비디올(CBD)이 제공하는 다양한 건강상의 이점에 대한 구매자의 의식 상승, 칸나비디올 오일과 주입 제품의 합법화 증가는 컨슈머 헬스 제품으로서 칸나비디올의 채용에 기여하고 있어 시장 성장에 긍정적인 영향을 미치고 있습니다. 게다가 헴프 유래의 칸나비디올 기반 제품에 대한 구매자의 인식과 태도의 변화가 예측 기간 동안의 수익 성장을 더욱 뒷받침하고 있습니다.

제품 유형에 따라 2019년에는 풀 스펙트럼 오일 부문이 시장을 독점했습니다. 칸나비디올 수요 증가의 요인으로는 제품 카테고리로서 칸나비디올에 대한 구매자의 기호가 높아지고, 풀 스펙트럼 증류물 수요 급증, 완제품 사업뿐만 아니라 벌크 사업에도 참가하는 기업이 많은 것 등을 들 수 있습니다. 한편, 영양 보조 식품 부문은 2019년에 48.3%의 점유율로 시장을 독점했습니다. 헬프 유래의 칸나비디올에 대한 정부의 호의적인 대처, 칸나비디올에 대한 의식의 높아짐, 영양 보조 식품에서 화학 베이스의 성분으로부터 오가닉 성분으로 구매자의 기호가 변화해, 시장을 견인하는 주된 요인이 되고 있습니다.

2019년에는 B2B 유통 채널 부문이 시장에서 가장 높은 수익 점유율을 차지했습니다. 이 성장은 의약품, 식품 및 첨가물, 건강 및 웰빙, 화장품 등 다양한 분야에서의 칸나비디올 오일 수요 증가에 기인하고 있습니다. 한편, 2019년에는 소매 약국이 시장을 독점했습니다. 소매 약국을 통해 제품을 판매하는 기업 증가가 이 분야의 성장을 뒷받침하고 있습니다.

북미는 입수의 용이성, 이용자들 사이에서 칸나비디올의 다양한 의료효과에 대한 인식이 높아지고 있는 점, 제조업체 수 증가로 2019년의 수익 점유율은 68.5%로 시장을 독점했습니다.

CBD 오일 및 CBD 컨슈머 헬스: 시장 보고서 하이라이트

• CBD 컨슈머 헬스 제품은 불안 해소와 통증 관리 등 칸나비디올(CBD) 제품과 관련된 건강 효과에 대한 소비자의 의식이 높아짐에 따라 시장을 독점했으며 2024년에는 56.0%의 점유율을 차지했습니다.
• CBD 오일 제품은 예측 기간 동안 20.9%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다. 소비자는 CBD 오일의 사용 편의성과 신속한 흡수를 지원하고 만성 통증과 수면 장애를 위한 선호 솔루션입니다.
• 북미의 CBD 오일 및 CBD 컨슈머 헬스 시장은 2024년 55.3%의 수익 점유율로 세계 시장을 독점했습니다. 이 지역 시장 성장은 규제 상황이 진행되고 있으며 대마초 유래 제품이 널리 받아 들여지고 있다는 것입니다.
• 아시아태평양 CBD 오일 및 CBD 컨슈머 헬스 시장은 예측기간에 39.3%의 가장 빠른 CAGR을 나타낼 것으로 예상되며, 증가하는 합법화 노력과 천연 건강 제품에 대한 소비자의 관심이 높아짐에 따라 추가되었습니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 CBD 오일 및 CBD 컨슈머 헬스 시장 : 변동 요인·경향·범위

• 시장 연관 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 CBD 오일 및 CBD 컨슈머 헬스 시장 : 제품별 비즈니스 분석

• 시장 점유율 : 유형별(2024년·2030년)
• 유형별 대시보드
• 시장 규모 예측과 동향 분석 : 유형별(2018-2030년)
• CBD 오일 시장
• CBD 컨슈머 헬스 시장

제5장 CBD 오일 및 CBD 컨슈머 헬스 시장 :지역 추정·동향 분석

• 시장 점유율 : 지역별(2024년·2030년)
• 시장 대시보드:지역별
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 국가별(2018-2030년)
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별(2018-2030년)
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 크로아티아
  • 폴란드
  • 네덜란드
  • 체코
  • 스위스
• 아시아태평양
  • 국가별(2018-2030년)
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 뉴질랜드
• 라틴아메리카
  • 국가별(2018-2030년)
  • 콜롬비아
  • 브라질
  • 아르헨티나
  • 칠레
  • 우루과이
• 중동 및 아프리카
  • 국가별(2018-2030년)
  • 남아프리카
  • 이스라엘

제6장 경쟁 구도

• 참가 기업 개요
• 기업 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 프로파일/상장 기업
  • CVSciences, Inc.
  • Medical Marijuana, Inc.
  • Charlotte's Web
  • ENDOCA
  • Isodiol International Inc
  • Elixinol
  • NuLeaf Naturals, LLC
  • Joy Organics
  • Kazmira
  • Lord Jones
  • AURORA CANNABIS INC.
  • Canopy Growth Corporation

JHS

영문 목차

영문목차

CBD Oil & CBD Consumer Health Market Growth & Trends:

The global CBD oil & CBD consumer health market size is expected to reach USD 215.9 billion by 2030, registering a CAGR of 20.9% from 2025 to 2030, according to a new report by Grand View Research, Inc.Growing buyer awareness regarding various health benefits offered by cannabidiol (CBD) and increasing legalization of cannabidiol oil and infused products is contributing towards the adoption of cannabidiol as a consumer health product, thereby positively impacting the market growth. Furthermore, changing buyer perception and attitude towards hemp-derived cannabidiol-based products is further bolstering revenue growth over the forecast period.

Based on the type of product, the full spectrum oil segment dominated the market in 2019. Factors contributing to the increase in demand for cannabidiol include rising buyer preference toward cannabidiol as a product category, the surge in demand for full-spectrum distillates, and many companies entering into bulk as well as finished product business. On the other hand, the nutraceuticals segment dominated the market with a share of 48.3% in 2019. Favorable government initiatives for hemp-derived cannabidiol, rising awareness regarding cannabidiol, and changing buyer preferences from chemical-based ingredients to organic ingredients in dietary supplements are the key factors driving the market.

In 2019, the B2B distribution channel segment accounted for the highest revenue share in the market. This growth is attributed to the increase in demand for cannabidiol oil in various sectors such as pharmaceutical, food and additives, health and wellness, and cosmetics. On the other hand, retail pharmacies dominated the market in 2019. The increase in the number of companies selling their products via retail pharmacies is fueling the growth of the segment.

North America dominated the market with a revenue share of 68.5% in 2019 owing to ease of accessibility, growing awareness regarding various medical benefits of cannabidiol among users, and the rise in the number of manufacturers.

CBD Oil & CBD Consumer Health Market Report Highlights:

• CBD consumer health products dominated the market and accounted for a share of 56.0% in 2024, owing to heightened consumer awareness of the health benefits associated with cannabidiol (CBD) products, including anxiety relief and pain management.
• CBD oil products are expected to grow at the fastest CAGR of 20.9% over the forecast period. Consumers favor CBD oil for its ease of use and rapid absorption, making it a preferred solution for chronic pain and sleep disorders.
• North America CBD oil & CBD consumer health market dominated the global market with a revenue share of 55.3% in 2024. Market growth in the region is its progressive regulatory landscape and wider acceptance of cannabis-derived products.
• Asia Pacific CBD oil & CBD consumer health market is expected to register the fastest CAGR of 39.3% in the forecast period, added by increasing legalization efforts and growing consumer interest in natural health products.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. CBD Oil & CBD Consumer Health Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. CBD Oil & CBD Consumer Health Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. CBD Oil Market
  • 4.4.1. CBD Oil Market, 2018 - 2030 (USD Million)
  • 4.4.2. CBD Oil
    • 4.4.2.1. CBD Oil Market, 2018 - 2030 (USD Million)
  • 4.4.3. CBD Isolate
    • 4.4.3.1. CBD Isolate Market, 2018 - 2030 (USD Million)
  • 4.4.4. Synthetic CBD
    • 4.4.4.1. Synthetic CBD Market, 2018 - 2030 (USD Million)
• 4.5. CBD Consumer Health Market
  • 4.5.1. CBD Consumer Health Market, 2018 - 2030 (USD Million)
  • 4.5.2. Medical OTC Products
    • 4.5.2.1. Medical OTC Products Market, 2018 - 2030 (USD Million)
    • 4.5.2.2. Analgesic
      • 4.5.2.2.1. Analgesic Market, 2018 - 2030 (USD Million)
      • 4.5.2.2.2. Oils
        • 4.5.2.2.2.1. Oils Market, 2018 - 2030 (USD Million)
      • 4.5.2.2.3. Pills/Capsules/Softgels
        • 4.5.2.2.3.1. Pills/Capsules/Softgels Market, 2018 - 2030 (USD Million)
      • 4.5.2.2.4. Topical
        • 4.5.2.2.4.1. Topical Market, 2018 - 2030 (USD Million)
    • 4.5.2.3. Mental Health
      • 4.5.2.3.1. Mental Health Market, 2018 - 2030 (USD Million)
      • 4.5.2.3.2. Oils
        • 4.5.2.3.2.1. Oils Market, 2018 - 2030 (USD Million)
      • 4.5.2.3.3. Pills/Capsules/Softgels
        • 4.5.2.3.3.1. Pills/Capsules/Softgels Market, 2018 - 2030 (USD Million)
    • 4.5.2.4. Dermatology
      • 4.5.2.4.1. Dermatology Market, 2018 - 2030 (USD Million)
    • 4.5.2.5. Sleep Aids
      • 4.5.2.5.1. Sleep Aids Market, 2018 - 2030 (USD Million)
      • 4.5.2.5.2. Oils
        • 4.5.2.5.2.1. Oils Market, 2018 - 2030 (USD Million)
      • 4.5.2.5.3. Pills/Capsules/Softgels
        • 4.5.2.5.3.1. Pills/Capsules/Softgels Market, 2018 - 2030 (USD Million)
      • 4.5.2.5.4. Oral Spray
        • 4.5.2.5.4.1. Oral Spray Market, 2018 - 2030 (USD Million)
    • 4.5.2.6. Others
      • 4.5.2.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5.3. Nutraceuticals
    • 4.5.3.1. Nutraceuticals Market, 2018 - 2030 (USD Million)
    • 4.5.3.2. VDS
      • 4.5.3.2.1. VDS Market, 2018 - 2030 (USD Million)
    • 4.5.3.3. Sports Nutrition
      • 4.5.3.3.1. Sports Nutrition Market, 2018 - 2030 (USD Million)
    • 4.5.3.4. Weight Management and Well-being
      • 4.5.3.4.1. Weight Management and Well-being Market, 2018 - 2030 (USD Million)
  • 4.5.4. Food & Beverages
    • 4.5.4.1. Food & Beverages Market, 2018 - 2030 (USD Million)
  • 4.5.5. Pharmaceuticals
    • 4.5.5.1. Pharmaceuticals Market, 2018 - 2030 (USD Million)
  • 4.5.6. Personal Care & Cosmetics
    • 4.5.6.1. Personal Care & Cosmetics Market, 2018 - 2030 (USD Million)
    • 4.5.6.2. CBD Infused Skincare Products
      • 4.5.6.2.1. CBD Infused Skincare Products Market, 2018 - 2030 (USD Million)
      • 4.5.6.2.2. Creams & Moisturizers
        • 4.5.6.2.2.1. Creams & Moisturizers Market, 2018 - 2030 (USD Million)
      • 4.5.6.2.3. Masks & Serums
        • 4.5.6.2.3.1. Masks & Serums Market, 2018 - 2030 (USD Million)
      • 4.5.6.2.4. Cleansers
        • 4.5.6.2.4.1. Cleansers Market, 2018 - 2030 (USD Million)
      • 4.5.6.2.5. Sunscreen
        • 4.5.6.2.5.1. Sunscreen Market, 2018 - 2030 (USD Million)
      • 4.5.6.2.6. Bath Bombs
        • 4.5.6.2.6.1. Bath Bombs Market, 2018 - 2030 (USD Million)
      • 4.5.6.2.7. Others
        • 4.5.6.2.7.1. Others Market, 2018 - 2030 (USD Million)
    • 4.5.6.3. CBD Infused Beauty Products
      • 4.5.6.3.1. CBD Infused Beauty Products Market, 2018 - 2030 (USD Million)
      • 4.5.6.3.2. Lip Balm & Gloss
        • 4.5.6.3.2.1. Lip Balm & Gloss Market, 2018 - 2030 (USD Million)
      • 4.5.6.3.3. Mascara
        • 4.5.6.3.3.1. Mascara Market, 2018 - 2030 (USD Million)
      • 4.5.6.3.4. Eyebrow Gels
        • 4.5.6.3.4.1. Eyebrow Gels Market, 2018 - 2030 (USD Million)
      • 4.5.6.3.5. Others
        • 4.5.6.3.5.1. Others Market, 2018 - 2030 (USD Million)
    • 4.5.6.4. CBD Infused Haircare Products
      • 4.5.6.4.1. CBD Infused Haircare Products Market, 2018 - 2030 (USD Million)
      • 4.5.6.4.2. Shampoos
        • 4.5.6.4.2.1. Shampoos Market, 2018 - 2030 (USD Million)
      • 4.5.6.4.3. Conditioners
        • 4.5.6.4.3.1. Conditioners Market, 2018 - 2030 (USD Million)
      • 4.5.6.4.4. Hair Serums
        • 4.5.6.4.4.1. Hair Serums Market, 2018 - 2030 (USD Million)

Chapter 5. CBD Oil & CBD Consumer Health Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 5.4. North America
  • 5.4.1. North America CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 5.4.2. U.S.
    • 5.4.2.1. Key Country Dynamics
    • 5.4.2.2. Regulatory Framework
    • 5.4.2.3. Competitive Insights
    • 5.4.2.4. U.S. CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Canada
    • 5.4.3.1. Key Country Dynamics
    • 5.4.3.2. Regulatory Framework
    • 5.4.3.3. Competitive Insights
    • 5.4.3.4. Canada CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Mexico
    • 5.4.4.1. Key Country Dynamics
    • 5.4.4.2. Regulatory Framework
    • 5.4.4.3. Competitive Insights
    • 5.4.4.4. Mexico CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.5. Europe
  • 5.5.1. Europe CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 5.5.2. UK
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Framework
    • 5.5.2.3. Competitive Insights
    • 5.5.2.4. UK CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Germany
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Framework
    • 5.5.3.3. Competitive Insights
    • 5.5.3.4. Germany CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. France
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Framework
    • 5.5.4.3. Competitive Insights
    • 5.5.4.4. France CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. Italy
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Regulatory Framework
    • 5.5.5.3. Competitive Insights
    • 5.5.5.4. Italy CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5.6. Croatia
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Regulatory Framework
    • 5.5.6.3. Competitive Insights
    • 5.5.6.4. Croatia CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5.7. Poland
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Regulatory Framework
    • 5.5.7.3. Competitive Insights
    • 5.5.7.4. Poland CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5.8. Netherlands
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Regulatory Framework
    • 5.5.8.3. Competitive Insights
    • 5.5.8.4. Netherlands CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5.9. Czech Republic
    • 5.5.9.1. Key Country Dynamics
    • 5.5.9.2. Regulatory Framework
    • 5.5.9.3. Competitive Insights
    • 5.5.9.4. Czech Republic CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5.10. Switzerland
    • 5.5.10.1. Key Country Dynamics
    • 5.5.10.2. Regulatory Framework
    • 5.5.10.3. Competitive Insights
    • 5.5.10.4. Switzerland CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Asia Pacific CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 5.6.2. Japan
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Framework
    • 5.6.2.3. Competitive Insights
    • 5.6.2.4. Japan CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. China
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Framework
    • 5.6.3.3. Competitive Insights
    • 5.6.3.4. China CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. India
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Framework
    • 5.6.4.3. Competitive Insights
    • 5.6.4.4. India CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6.5. South Korea
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Framework
    • 5.6.5.3. Competitive Insights
    • 5.6.5.4. South Korea CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6.6. Australia
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Framework
    • 5.6.6.3. Competitive Insights
    • 5.6.6.4. Australia CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6.7. New Zealand
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Regulatory Framework
    • 5.6.7.3. Competitive Insights
    • 5.6.7.4. New Zealand CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Latin America CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 5.7.2. Colombia
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Framework
    • 5.7.2.3. Competitive Insights
    • 5.7.2.4. Colombia CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. Brazil
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Framework
    • 5.7.3.3. Competitive Insights
    • 5.7.3.4. Brazil CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7.4. Argentina
    • 5.7.4.1. Key Country Dynamics
    • 5.7.4.2. Regulatory Framework
    • 5.7.4.3. Competitive Insights
    • 5.7.4.4. Argentina CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7.5. Chile
    • 5.7.5.1. Key Country Dynamics
    • 5.7.5.2. Regulatory Framework
    • 5.7.5.3. Competitive Insights
    • 5.7.5.4. Chile CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7.6. Uruguay
    • 5.7.6.1. Key Country Dynamics
    • 5.7.6.2. Regulatory Framework
    • 5.7.6.3. Competitive Insights
    • 5.7.6.4. Uruguay CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.8. MEA
  • 5.8.1. MEA CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 5.8.2. South Africa
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Framework
    • 5.8.2.3. Competitive Insights
    • 5.8.2.4. South Africa CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.8.3. Israel
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Regulatory Framework
    • 5.8.3.3. Competitive Insights
    • 5.8.3.4. Israel CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. CVSciences, Inc.
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial Performance
    • 6.5.1.3. Product Benchmarking
    • 6.5.1.4. Strategic Initiatives
  • 6.5.2. Medical Marijuana, Inc.
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial Performance
    • 6.5.2.3. Product Benchmarking
    • 6.5.2.4. Strategic Initiatives
  • 6.5.3. Charlotte's Web
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial Performance
    • 6.5.3.3. Product Benchmarking
    • 6.5.3.4. Strategic Initiatives
  • 6.5.4. ENDOCA
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial Performance
    • 6.5.4.3. Product Benchmarking
    • 6.5.4.4. Strategic Initiatives
  • 6.5.5. Isodiol International Inc
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial Performance
    • 6.5.5.3. Product Benchmarking
    • 6.5.5.4. Strategic Initiatives
  • 6.5.6. Elixinol
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial Performance
    • 6.5.6.3. Product Benchmarking
    • 6.5.6.4. Strategic Initiatives
  • 6.5.7. NuLeaf Naturals, LLC
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial Performance
    • 6.5.7.3. Product Benchmarking
    • 6.5.7.4. Strategic Initiatives
  • 6.5.8. Joy Organics
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial Performance
    • 6.5.8.3. Product Benchmarking
    • 6.5.8.4. Strategic Initiatives
  • 6.5.9. Kazmira
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial Performance
    • 6.5.9.3. Product Benchmarking
    • 6.5.9.4. Strategic Initiatives
  • 6.5.10. Lord Jones
    • 6.5.10.1. Overview
    • 6.5.10.2. Financial Performance
    • 6.5.10.3. Product Benchmarking
    • 6.5.10.4. Strategic Initiatives
  • 6.5.11. AURORA CANNABIS INC.
    • 6.5.11.1. Overview
    • 6.5.11.2. Financial Performance
    • 6.5.11.3. Product Benchmarking
    • 6.5.11.4. Strategic Initiatives
  • 6.5.12. Canopy Growth Corporation
    • 6.5.12.1. Overview
    • 6.5.12.2. Financial Performance
    • 6.5.12.3. Product Benchmarking
    • 6.5.12.4. Strategic Initiatives

관련자료